NO960723L - Inhibitorer for TNF-alfa-sekresjon - Google Patents
Inhibitorer for TNF-alfa-sekresjonInfo
- Publication number
- NO960723L NO960723L NO960723A NO960723A NO960723L NO 960723 L NO960723 L NO 960723L NO 960723 A NO960723 A NO 960723A NO 960723 A NO960723 A NO 960723A NO 960723 L NO960723 L NO 960723L
- Authority
- NO
- Norway
- Prior art keywords
- tnf
- inhibitors
- alpha secretion
- tace
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06086—Dipeptides with the first amino acid being basic
- C07K5/06095—Arg-amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06086—Dipeptides with the first amino acid being basic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Crystallography & Structural Chemistry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Det er beskrevet forbindelser og fremgangsmåter som kan anvendes til inhibering av det TNF-a-omdannende enzym (TACE) som er ansvarlig for spalting av TNF-ct-forløper, hvorved det fås biologisk aktiv TNF-a. Forbindel- sene som anvendes ved oppfinnelsen, er peptidylderivater med aktive grupper som er i stand til å inhibere TACE, slik som hydroksamater, tioler, fosfo- ryler og karboksyler.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11060193A | 1993-08-23 | 1993-08-23 | |
US18301994A | 1994-01-18 | 1994-01-18 | |
PCT/US1994/009343 WO1995006031A1 (en) | 1993-08-23 | 1994-08-19 | Inhibitors of tnf-alpha secretion |
Publications (2)
Publication Number | Publication Date |
---|---|
NO960723D0 NO960723D0 (no) | 1996-02-23 |
NO960723L true NO960723L (no) | 1996-02-23 |
Family
ID=26808203
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO960723A NO960723L (no) | 1993-08-23 | 1996-02-23 | Inhibitorer for TNF-alfa-sekresjon |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0715619A4 (no) |
JP (1) | JPH09503201A (no) |
AU (2) | AU687436B2 (no) |
CA (1) | CA2170158A1 (no) |
FI (1) | FI960803A (no) |
NO (1) | NO960723L (no) |
NZ (1) | NZ271893A (no) |
WO (1) | WO1995006031A1 (no) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3787605B2 (ja) * | 1994-10-05 | 2006-06-21 | ダーウィン・ディスカバリー・リミテッド | ペプチジル化合物および金属プロテアーゼのインヒビターとしてのその治療的使用 |
JPH11504646A (ja) * | 1995-05-10 | 1999-04-27 | カイロサイエンス・リミテッド | 金属プロテアーゼとtnfの放出を抑制するペプチド化合物およびその治療的使用 |
AU706064B2 (en) * | 1995-05-10 | 1999-06-10 | Darwin Discovery Limited | Peptide compounds which inhibit metalloproteinase and TNF liberation, and their therapeutic use |
DE69627483T2 (de) * | 1995-05-10 | 2004-04-01 | Darwin Discovery Ltd., Slough | Peptidartige stoffe, die metalloproteinasen und die tnf-freisetzung hemmen, und ihre therapeutische verwendung |
US6406901B1 (en) | 1995-06-08 | 2002-06-18 | Immunex Corporation | TNF-a converting enzyme |
US5883241A (en) * | 1995-09-05 | 1999-03-16 | Celltech Therapeutics Limited | DNA sequences coding for a human metalloproteinase and variants thereof |
HUP0003760A3 (en) * | 1995-10-05 | 2001-05-28 | Darwin Discovery Ltd Cambridge | Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation, process for production thereof and their use |
US5665777A (en) * | 1995-11-14 | 1997-09-09 | Abbott Laboratories | Biphenyl hydroxamate inhibitors of matrix metalloproteinases |
AU711804B2 (en) | 1995-11-23 | 1999-10-21 | British Biotech Pharmaceuticals Limited | Metalloproteinase inhibitors |
GB9607120D0 (en) * | 1996-04-04 | 1996-06-12 | Chiroscience Ltd | Compounds |
US5990293A (en) * | 1996-09-05 | 1999-11-23 | Celltech Therapeutics Limited | Human metalloproteinase, variants thereof and DNA sequence coding therefor |
US6169075B1 (en) | 1996-09-10 | 2001-01-02 | British Biotech Pharmaceuticals Limited | Cytostatic agents |
US6462023B1 (en) | 1996-09-10 | 2002-10-08 | British Biotech Pharmaceuticals, Ltd. | Cytostatic agents |
US5952320A (en) * | 1997-01-07 | 1999-09-14 | Abbott Laboratories | Macrocyclic inhibitors of matrix metalloproteinases and TNFα secretion |
ZA9818B (en) * | 1997-01-07 | 1998-07-02 | Abbott Lab | C-terminal ketone inhibitors of matrix metalloproteinases and tnf alpha secretion |
US5985911A (en) * | 1997-01-07 | 1999-11-16 | Abbott Laboratories | C-terminal ketone inhibitors of matrix metalloproteinases and TNFα secretion |
EP1001805A1 (en) * | 1997-06-18 | 2000-05-24 | The Rockefeller University | Methods for identifying antibodies and peptides useful in the treatment of septic shock and experimental arthritis and uses thereof |
AU9449398A (en) * | 1997-10-10 | 1999-05-03 | Imperial College Innovations Ltd. | Use of csaidtm compounds for the management of uterine contractions |
GB9810464D0 (en) | 1998-05-16 | 1998-07-15 | British Biotech Pharm | Hydroxamic acid derivatives |
US6329400B1 (en) | 1998-08-26 | 2001-12-11 | Glaxo Wellcome Inc. | Formamide compounds as therapeutic agents |
US6172064B1 (en) | 1998-08-26 | 2001-01-09 | Glaxo Wellcome Inc. | Formamides as therapeutic agents |
GB9818605D0 (en) | 1998-08-26 | 1998-10-21 | Glaxo Group Ltd | Formamide compounds as therepeutic agents |
US6300341B1 (en) | 1998-09-30 | 2001-10-09 | The Procter & Gamble Co. | 2-substituted heterocyclic sulfonamides |
WO2000018358A2 (en) * | 1998-09-30 | 2000-04-06 | The Procter & Gamble Company | Method of treating hair loss using ketoamides |
US6307049B1 (en) | 1998-09-30 | 2001-10-23 | The Procter & Gamble Co. | Heterocyclic 2-substituted ketoamides |
JP2002525305A (ja) * | 1998-09-30 | 2002-08-13 | ザ、プロクター、エンド、ギャンブル、カンパニー | スルホンアミドを用いた脱毛治療の方法 |
US6288261B1 (en) | 1998-12-18 | 2001-09-11 | Abbott Laboratories | Inhibitors of matrix metalloproteinases |
US6329550B1 (en) | 1998-12-31 | 2001-12-11 | Aventis Pharmaceuticals Inc. | Amidomalonamides useful as inhibitors of MMP of matrix metalloproteinase |
BR0007491A (pt) * | 1999-01-13 | 2001-11-20 | Jomaa Pharmaka Gmbh | Uso de 3-isoxazolidinonas e ácidos hidroxilâmicospara o tratamento de infecções |
US20040220103A1 (en) | 1999-04-19 | 2004-11-04 | Immunex Corporation | Soluble tumor necrosis factor receptor treatment of medical disorders |
GB9922825D0 (en) * | 1999-09-25 | 1999-11-24 | Smithkline Beecham Biolog | Medical use |
WO2002006227A1 (fr) * | 2000-07-18 | 2002-01-24 | Chugai Seiyaku Kabushiki Kaisha | Inhibiteurs de la metalloprotease matricielle |
AU2002230385A1 (en) * | 2000-09-25 | 2002-04-15 | Questcor Pharmaceuticals, Inc. | Peptide deformylase inhibitors |
PE20030701A1 (es) | 2001-12-20 | 2003-08-21 | Schering Corp | Compuestos para el tratamiento de trastornos inflamatorios |
AU2019352741A1 (en) | 2018-10-04 | 2021-05-06 | Assistance Publique-Hôpitaux De Paris (Aphp) | EGFR inhibitors for treating keratodermas |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR870700065A (ko) * | 1984-12-19 | 1987-02-28 | 아놀드 자일러, 에른스트 알테르 | 신규한 카본산 에스테르 |
FR2609289B1 (fr) * | 1987-01-06 | 1991-03-29 | Bellon Labor Sa Roger | Nouveaux composes a activite d'inhibiteurs de collagenase, procede pour les preparer et compositions pharmaceutiques contenant ces composes |
GB9102635D0 (en) * | 1991-02-07 | 1991-03-27 | British Bio Technology | Compounds |
WO1992022523A2 (en) * | 1991-06-14 | 1992-12-23 | Research Corporation Technologies, Inc. | Peptide derivatives of collagenase inhibitor |
GB9215665D0 (en) * | 1992-07-23 | 1992-09-09 | British Bio Technology | Compounds |
GB9323165D0 (en) * | 1993-11-10 | 1994-01-05 | Chiros Ltd | Compounds |
GB9411088D0 (en) * | 1994-06-03 | 1994-07-27 | Hoffmann La Roche | Hydroxylamine derivatives |
-
1994
- 1994-08-19 NZ NZ271893A patent/NZ271893A/en unknown
- 1994-08-19 WO PCT/US1994/009343 patent/WO1995006031A1/en not_active Application Discontinuation
- 1994-08-19 AU AU75694/94A patent/AU687436B2/en not_active Ceased
- 1994-08-19 JP JP7507668A patent/JPH09503201A/ja active Pending
- 1994-08-19 CA CA002170158A patent/CA2170158A1/en not_active Abandoned
- 1994-08-19 EP EP94925940A patent/EP0715619A4/en not_active Ceased
-
1996
- 1996-02-22 FI FI960803A patent/FI960803A/fi unknown
- 1996-02-23 NO NO960723A patent/NO960723L/no unknown
-
1998
- 1998-01-06 AU AU50302/98A patent/AU5030298A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
NO960723D0 (no) | 1996-02-23 |
FI960803A0 (fi) | 1996-02-22 |
FI960803A (fi) | 1996-04-22 |
CA2170158A1 (en) | 1995-03-02 |
EP0715619A4 (en) | 1997-03-19 |
WO1995006031A1 (en) | 1995-03-02 |
EP0715619A1 (en) | 1996-06-12 |
AU7569494A (en) | 1995-03-21 |
AU687436B2 (en) | 1998-02-26 |
AU5030298A (en) | 1998-03-05 |
NZ271893A (en) | 1997-11-24 |
JPH09503201A (ja) | 1997-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO960723L (no) | Inhibitorer for TNF-alfa-sekresjon | |
MY129998A (en) | Saccharin derivative proteolytic enzyme inhibitors | |
Harris et al. | Pseudosubstrate inhibition of cyclic AMP-dependent protein kinase in intact pancreatic islets: effects on cyclic AMP-dependent and glucose-dependent insulin secretion | |
MY110104A (en) | Saccharin derivative proteolytic enzyme inhibitors | |
NO20051788L (no) | Hydantoinderivater og deres anvendelse som TACE-inhibitorer | |
DK204290D0 (da) | Enzymatisk detergentkomposition og fremgangsmaade til enzymstabilisering | |
BG103977A (en) | Low molecular rotamase enzymic activity inhibitors | |
BR9908280A (pt) | Inibidores de enzimas de fosfolipase | |
PT691988E (pt) | Inibidor da proliferacao de celulas estaminais e suas utilizacoes | |
AU2002341715A1 (en) | Cyclic hydroxamic acids as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme (tace) | |
MY135732A (en) | 5,6-trimethylenepyrimidin - 4 - one compounds | |
BR0010220A (pt) | Compostos de pirimidinona | |
NO961888D0 (no) | Peptidylforbindelser og deres terapeutiske anvendelse som inhibitorer av metallproteinaser | |
DK0938570T3 (da) | Muteret alfa-amylase omfattende modifikation ved rester svarende til A210, H405 og/eller T412 i Bacillus licheniformis | |
DK0719154T3 (da) | Aktiveret faktor VIII som terapeutisk middel og metode til behandling af faktor VIII-mangel | |
NZ503962A (en) | ACE inhibitor (angiotensin converting enzyme) and MMP (matrix metalloproteinase inhibitor) combinations for treating fibrosis | |
PT784677E (pt) | Inibidor da proliferacaode celulas estaminais e suas utilizacoes | |
NO914217D0 (no) | Sakkarinderivater nyttige som proteolytiske enzyminhibitorer og fremstilling derav | |
WO2004052236A3 (en) | Methods and compositions for treatment of otitis media | |
BR0213994A (pt) | Derivados heterocìclicos de glicinamida e seus usos médicos | |
Kress et al. | Effects of human plasma α2 macroglobulin on the proteolytic activity of snake venoms | |
Murachi et al. | Inhibition of stem bromelain by the chloromethyl ketone derivatives of N-tosyl-L-phenylalanine and N-tosyl-L-lysine | |
AU2158200A (en) | Novel inhibitors of farnesyl-protein transferase | |
Petrovan et al. | Purification and characterization of multisquamase, the prothrombin activator present in Echis multisquamatus venom | |
DK0977495T3 (da) | Sammensætning indeholdende pektinmethylesterase og to substrater |